SRE Holdings (2980) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 Sep, 2025Executive summary
Achieved strong growth in both revenue and profit, driven by expansion in AI Cloud & Consulting and Life & Property Solutions segments.
Acquired MEDIX Co., Ltd., boosting healthcare sector presence and recurring revenue.
Launched new services and collaborations, including with Paramount Bed and Mizuho Bank.
Financial highlights
Net sales rose 10.2% year-over-year to ¥26,690.9 million; operating profit up 40.5% to ¥3,108.0 million.
Ordinary profit increased 41.1% to ¥2,903.8 million; profit attributable to owners of parent up 22.2% to ¥1,697.1 million.
Basic EPS was ¥105.46, up from ¥85.83 year-over-year.
Comprehensive income grew 26.4% to ¥1,842.7 million.
Outlook and guidance
Forecast for FY2026: net sales ¥35,000 million (+31.1%), operating profit ¥4,050 million (+30.3%), ordinary profit ¥3,650 million (+25.7%), profit attributable to owners of parent ¥2,220 million (+30.8%), basic EPS ¥137.88.
AI Cloud & Consulting segment targets 33% sales growth and 38% operating profit growth, focusing on healthcare and SaaS expansion.
Life & Property Solutions expects 35% sales and 14% operating profit growth, with a 43% increase in AUM.
Latest events from SRE Holdings
- Record profit and revenue growth driven by AI and real estate, with strong outlook.2980
Q3 202610 Feb 2026 - Profits fell sharply, but AI and healthcare segments grew; strong 2H recovery expected.2980
Q2 202611 Nov 2025 - Sales declined and a net loss was posted, but AI Cloud & Consulting showed strong growth.2980
Q1 20268 Sep 2025 - Strong sales and profit growth driven by segment expansion and Medix acquisition.2980
Q1 20258 Sep 2025 - Double-digit sales and profit growth, boosted by Medix acquisition and segment expansion.2980
Q2 20258 Sep 2025 - Sales up 12.6% but profit down 31.7%; Medix acquisition drives asset and goodwill growth.2980
Q3 20258 Sep 2025